Showing results (221-230 of 282) with videos related to

Sort By:
Pageof 29
International Journal of Cancer|December 15, 1990
Type-II estrogen binding sites in a lymphoblastoid cell line and growth-inhibitory effect of estrogen, anti-estrogen and bioflavonoidsG Scambia, F O Ranelletti, P Benedetti Panici, et al.
Gynecologic Oncology|July 1, 1996
Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomyP Benedetti-Panici, F Maneschi, G Scambia, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Synergistic antiproliferative activity of tamoxifen and cisplatin on primary ovarian tumoursG Scambia, F O Ranelletti, P Benedetti Panici, et al.
Gynecologic Oncology|April 1, 1995
Bisdioxopiperazine, (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF 187), enhances the antiproliferative effect of cisplatin on human ovarian cancer cellsG Scambia, R Della Bitta, P Benedetti Panici, et al.
British Journal of Cancer|January 15, 1999
Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell linesC Ferlini, G Scambia, M Marone, et al.
International Journal of Cancer|April 9, 1998
Comparative study on the induction of cytostasis and apoptosis by ICI 182,780 and tamoxifen in an estrogen receptor-negative ovarian cancer cell lineA Ercoli, G Scambia, A Fattorossi, et al.
Public Health|November 1, 1989
A national voice for information about HIV infections: the Italian state AIDS hot-lineM Tumbarello, M Giuliani, P Benedetti, et al.
Cancer Letters|November 12, 1996
Tamoxifen synergizes the antiproliferative effect of cisplatin in human ovarian cancer cells: enhancement of DNA platination as a possible mechanismA Ercoli, G Scambia, R De Vincenzo, et al.
Cancer Treatment Reviews|June 1, 1989
Recombinant interleukin-2 continuous infusion in ovarian cancer patients with minimal residual disease at second-lookP Benedetti Panici, G Scambia, S Greggi, et al.
Gynecologic Oncology|May 11, 2011
A prospective phase II study of topotecan (Hycamtin®) and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancerN Manci, C Marchetti, C Di Tucci, et al.
Pageof 29